EP
TMO icon

Essential Partners’s Thermo Fisher Scientific TMO Stock Holding History

Essential Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.8K Buy
193
+118
+157% +$56.6K 0.04% 428
2026
Q1 		$36.9K Buy
75
+7
+10% +$3.8K 0.01% 684
2025
Q4 		$39.4K Buy
68
+4
+6% +$2.26K 0.01% 672
2025
Q3 		$31K Buy
64
+11
+21% +$5.12K 0.01% 744
2025
Q2 		$21.5K Buy
+53
New +$22.2K 0.01% 655

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Essential Partners's TMO Position: Q2 2026 in Review

Essential Partners increased its Thermo Fisher Scientific (TMO) stake by 157% in Q2 2026, buying an estimated $56.6K and bringing the position to 193 shares worth $96.8K. The position accounts for 0.04% of the portfolio, ranked #428.

Essential Partners first reported a position in TMO in Q2 2025 and has held it in 5 quarters since. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Essential Partners held 193 shares of Thermo Fisher Scientific worth $96.8K as of Q2 2026.
  • Essential Partners bought 118 Thermo Fisher Scientific shares in Q2 2026, an estimated $56.6K.
  • Thermo Fisher Scientific made up 0.04% of Essential Partners's portfolio in Q2 2026, its #428 holding.
  • Essential Partners first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 5 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.